INFECTION IN AN IMMUNOCOMPROMISED HOST side effect
What is INFECTION IN AN IMMUNOCOMPROMISED HOST ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
INFECTION IN AN IMMUNOCOMPROMISED HOST and Recently Reported Side Effects
INFECTION IN AN IMMUNOCOMPROMISED HOST and 15 most Active Side Effect polls
INFECTION IN AN IMMUNOCOMPROMISED HOST and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with INFECTION IN AN IMMUNOCOMPROMISED HOST
AZATHIOPRINE BETASERON CYTARABINE DOXORUBICIN ENBREL GLEEVEC HUMIRA KLACID LANSOPRAZOLE LEUPROLIDE PROGRAF REBIF REMICADE REVLIMID VELCADE VIVITROLRemicade Side Effects Report #5387247-5
Physician from SWEDEN reported REMICADE problem on July 06, 2007. Female patient, 58 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, urinary tract infection, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.
Remicade Side Effects Report #5388893-5
REMICADE problem was reported by a Physician from SWEDEN on July 06, 2007. Female patient, 62 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, syncope, . REMICADE dosage: unknown. Patient recovered.
Remicade Side Effects Report #5387247-5
Physician from SWEDEN reported REMICADE problem on July 06, 2007. Female patient, 58 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, urinary tract infection, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.
Remicade Side Effects Report #5388893-5
REMICADE problem was reported by a Physician from SWEDEN on July 06, 2007. Female patient, 62 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, syncope, . REMICADE dosage: unknown. Patient recovered.
Cytarabine Side Effects Report #5299724-6
Consumer or non-health professional from ROMANIA reported CYTARABINE problem on Mar 26, 2007. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, pancytopenia, pleural effusion, pneumonia, . CYTARABINE dosage: 20 MG/M2. During the same period patient was treated with PREDNISONE, METOPROLOL SUCCINATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Vivitrol Side Effects Report #5261930-4
VIVITROL problem was reported by a Physician from UNITED STATES on Feb 22, 2007. Male patient, 52 years of age, was treated with VIVITROL. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, sepsis, . VIVITROL dosage: unknown. During the same period patient was treated with WELLBUTRIN, CRESTOR, ALTACE, FOLIC ACID, ADVAIR DISKUS, BACLOFEN, ZOFRAN. Patient died on 01/19/2007.
Prograf Side Effects Report #5678851-5
Consumer or non-health professional from UNITED STATES reported PROGRAF problem on Mar 12, 2008. Male patient, 33 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, infection in an immunocompromised host, kidney infection, renal transplant, surgical procedure repeated, . PROGRAF dosage: 3.5 MG, BID, ORAL. During the same period patient was treated with CELLCEPT, PREDNISOLONE ACETATE. Patient recovered.
Remicade Side Effects Report #5610599-5
REMICADE problem was reported by a Physician from SWEDEN on Jan 18, 2008. Female patient, 26 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, infection in an immunocompromised host, nausea, pneumonia, sinusitis, urinary tract infection, vomiting, weight decreased, . REMICADE dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, OMEPRAZOLE, METHOTREXATE, PREDNISOLONE. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5602273-6
Physician from SWEDEN reported REMICADE problem on Jan 18, 2008. Female patient, 33 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: abscess jaw, infection in an immunocompromised host, knee operation, oral pain, upper respiratory tract infection, . REMICADE dosage: unknown. During the same period patient was treated with VOLTAREN, METHOTREXATE, CURADON. Patient was hospitalized. Patient recovered.
Enbrel Side Effects Report #5556964-6
ENBREL problem was reported by a Pharmacist from UNITED STATES on Sept 20, 2007. Male patient, 51 years of age, was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: gastrointestinal infection, infection in an immunocompromised host, viral infection, . ENBREL dosage: unknown. Patient recovered.
Betaseron Side Effects Report #5451578-0
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Sept 04, 2007. Male patient, 53 years of age, weighting 210.0 lb, was diagnosed with secondary progressive multiple sclerosis, asthma and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: aspiration, infection in an immunocompromised host, lung infection, . BETASERON dosage: unknown. During the same period patient was treated with AMITRIPTYLINE, ALBUTEROL, MONTELUKAST, ATROVENT. Patient recovered.
Prograf Side Effects Report #5453493-5
PROGRAF problem was reported by a Physician from UNITED STATES on Aug 24, 2007. Female patient, 48 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: hair disorder, infection in an immunocompromised host, viral infection, . PROGRAF dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL. Patient recovered.
Humira Side Effects Report #5714983-0
Health Professional from SWEDEN reported HUMIRA problem on Apr 14, 2008. Female patient, 43 years of age, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: appendicitis, infection in an immunocompromised host, . HUMIRA dosage: unknown. During the same period patient was treated with ZELOKEN ZOC PROLONGED RELEASELET, OMEPRAZOLE, PARACETAMOL, PREDNISOLONE, ORUDIS GEL, CELECOXIB. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5340058-9
LEUPROLIDE ACETATE problem was reported by a Consumer or non-health professional from JAPAN on May 22, 2007. Male patient was diagnosed with prostate cancer and was treated with LEUPROLIDE ACETATE. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, interstitial lung disease, respiratory failure, . LEUPROLIDE ACETATE dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient died.
Doxorubicin Side Effects Report #5316475-X
Health Professional from NORWAY reported DOXORUBICIN problem on Apr 18, 2007. Female patient, 49 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: immunodeficiency, infection in an immunocompromised host, pneumocystis jiroveci pneumonia, . DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.
Doxorubicin Side Effects Report #5316584-5
DOXORUBICIN problem was reported by a Health Professional from NORWAY on Apr 18, 2007. Female patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: immunodeficiency, infection in an immunocompromised host, pneumocystis jiroveci pneumonia, . DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.
Doxorubicin Side Effects Report #5316601-2
Health Professional from NORWAY reported DOXORUBICIN problem on Apr 18, 2007. Female patient, 30 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: immunodeficiency, infection in an immunocompromised host, pneumocystis jiroveci pneumonia, . DOXORUBICIN dosage: 50 MG/M2 PER_CYCLE IV. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.
Velcade Side Effects Report #5679438-0
VELCADE problem was reported by a Physician from FRANCE on Mar 04, 2008. Male patient, 58 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: brain abscess, endocarditis staphylococcal, infection in an immunocompromised host, pleurisy, staphylococcal sepsis, . VELCADE dosage: 2.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Azathioprine Side Effects Report #5502280-8
Health Professional from GREECE reported AZATHIOPRINE problem on Oct 15, 2007. Female patient, child 7 years of age, weighting 55.12 lb, was diagnosed with vasculitis and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: histiocytosis haematophagic, immunosuppression, infection in an immunocompromised host, parvovirus infection, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with KINERET, PREDNISONE, CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE, ETANERCEPT, METHOTREXATE, CYCLOSPORINE. Patient died on 05/12/2007.
Revlimid Side Effects Report #5463029-0
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2007. Male patient was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cellulitis staphylococcal, infection in an immunocompromised host, myositis, pancytopenia, . REVLIMID dosage: 5MG DAILY PO. During the same period patient was treated with PROCRIT, ALLOPURINOL, TEMAZEPAM, PENTOXIFYLLINE, OMEPRAZOLE, FLUOXETINE, NIFEDIPINE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Gleevec Side Effects Report #5690138-3
Consumer or non-health professional from JAPAN reported GLEEVEC problem on Mar 17, 2008. Male patient, 54 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: hypoglobulinaemia, immunodeficiency, infection in an immunocompromised host, pneumonia bacterial, . GLEEVEC dosage: unknown. Patient recovered.
Klacid Side Effects Report #5694122-5
KLACID OD problem was reported by a Health Professional from PORTUGAL on Mar 26, 2008. Female patient, weighting 132.3 lb, was diagnosed with tooth abscess, depression and was treated with KLACID OD. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, . KLACID OD dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, TRAMADOL, MAPROTILINE HYDROCHLORIDE, ALPRAZOLAM. Patient recovered.
Rebif Side Effects Report #5325713-9
Physician from UNITED STATES reported REBIF problem on Apr 27, 2007. Male patient, 49 years of age, weighting 180.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: herpes zoster, hyperaesthesia, infection in an immunocompromised host, pain, rash pustular, . REBIF dosage: unknown. During the same period patient was treated with COLAZAL, LEVSINEX, LAMICTAL, IMURAN, MAXZIDE, LIPITOR, PROMETHAZINE, ALEVE. Patient was hospitalized. Patient recovered.
Prograf Side Effects Report #5305184-9
PROGRAF problem was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Male patient, 70 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: band neutrophil count increased, complications of transplanted kidney, infection in an immunocompromised host, lung adenocarcinoma, meningitis cryptococcal, neutropenia, renal failure, shift to the left, sinusitis, . PROGRAF dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, NYSTATIN, TOPROL, CADUET, VASOTEC, SYNTHROID, PROTONIX. Patient was hospitalized. Patient recovered.
Lansoprazole Side Effects Report #5307008-2
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Apr 17, 2007. Male patient, 62 years of age, was diagnosed with erosive duodenitis, gastritis erosive, reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, cytomegalovirus enterocolitis, infection in an immunocompromised host, interstitial lung disease, nasopharyngitis, pneumocystis jiroveci pneumonia, rash, small intestinal perforation, . LANSOPRAZOLE dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with RABEPRAZOLE. Patient was hospitalized. Patient died.
Humira Side Effects Report #5281208-2
HUMIRA problem was reported by a Pharmacist from UNITED KINGDOM on Mar 23, 2007. Female patient, weighting 182.2 lb, was diagnosed with rheumatoid arthritis, hypertension, diabetes mellitus, muscle spasms, hypothyroidism, analgesic effect and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, infection in an immunocompromised host, urinary tract infection, . HUMIRA dosage: unknown. During the same period patient was treated with CANDESARTAN, METFORMIN, GLICLAZIDE, QUININE, LEVOTHYROXINE, TRAMADOL, ACETAMINOPHEN. Patient recovered.